<DOC>
	<DOCNO>NCT00945334</DOCNO>
	<brief_summary>In study investigator aim compare efficacy neomycin combination rifaximin neomycin treatment C-IBS subject methane breath test . This study conduct collaboration Dr. John DiBaise Mayo Clinic Scottsdale , AZ Dr. Satish Rao Georgia Regents University Augusta , GA .</brief_summary>
	<brief_title>Neomycin Rifaximin Plus Neomycin Treating Methane Positive Constipation Predominant Irritable Bowel Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Constipation</mesh_term>
	<mesh_term>Irritable Bowel Syndrome</mesh_term>
	<mesh_term>Rifaximin</mesh_term>
	<mesh_term>Rifamycins</mesh_term>
	<mesh_term>Neomycin</mesh_term>
	<criteria>Rome III positive IBS subject ( 1875 year age ) Meet criterion constipation predominant IBS symptom include ≤ 3 complete spontaneous bowel movement per week hard lumpy stool . Presence detectable methane single breath sample ( ≥ 3ppm ) . If subject ≥ 50 year old , colonoscopy complete within past 5 year . Subjects history intestinal surgery ( except appendectomy cholecystectomy ) Recent antibiotic use ( within last 30 day ) Subjects know pelvic floor dysfunction Pregnancy Creatinine level &gt; 1.4 Poorly controlled/uncontrolled significant medical condition would interfere study procedure Subjects hearing loss and/or tinnitus History bowel obstruction History celiac disease History inflammatory bowel disease Cirrhosis Diabetes</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>Constipation predominant Irritable Bowel Syndrome</keyword>
</DOC>